MC
KALA icon

Matisse Capital’s KALA BIO KALA Stock Holding History

Matisse Capital’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15
Closed -$11K – 106
2022
Q2 		$11K Hold
15
– – 0.01% 124
2022
Q1 		$51K Sell
15
-2
-12% -$5.24K 0.05% 121
2021
Q4 		$50K Sell
17
-5
-23% -$23.2K 0.03% 135
2021
Q3 		$147K Hold
22
– – 0.05% 140
2021
Q2 		$297K Hold
22
– – 0.09% 123
2021
Q1 		$378K Hold
22
– – 0.11% 130
2020
Q4 		$378K Buy
22
+2
+10% +$37.6K 0.12% 120
2020
Q3 		$377K Hold
20
– – 0.15% 103
2020
Q2 		$529K Sell
20
-12
-38% -$340K 0.18% 94
2020
Q1 		$713K Buy
32
+10
+45% +$160K 0.28% 81
2019
Q4 		$201K Buy
22
+3
+16% +$29K 0.14% 100
2019
Q3 		$177K Buy
19
+1
+6% +$12.2K 0.22% 85
2019
Q2 		$284K Buy
18
+1
+6% +$16.6K 0.36% 69
2019
Q1 		$361K Buy
+17
New +$302K 0.44% 56

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Matisse Capital's KALA Position: Q3 2022 in Review

Matisse Capital sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 15 shares — an estimated $11K sold.

Matisse Capital first reported a position in KALA in Q1 2019 and held it in 14 quarters. The position peaked at $713K in Q1 2020. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Matisse Capital reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Matisse Capital sold 15 KALA BIO shares in Q3 2022, an estimated $11K.
  • Matisse Capital first reported a position in KALA BIO in Q1 2019 and held it in 14 quarters.
  • Matisse Capital's KALA BIO position peaked at $713K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Matisse Capital's 13F filing for Q3 2022, filed 8 Nov 2022.